P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin's lymphoma

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; p. 47
Main Authors Mangasarova, Ya.K., Moiseeva, T.N., Al‐Radi, L.S., Margolin, O.V., Gorenkova, L.G., Nesterova, E.S., Bagova, M.O., Fastova, E.A., Abdurashidova, R.R., Sarakaeva, Z.T., Dorokhina, Elena, Kravchenko, S.K., Magomedova, A.U., Zvonkov, E.E.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 03.10.2022
Wiley
Subjects
Relapsed/Refractory
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000890972.83229.41